SERA PROGNOSTICS, INC. Operating Cash Flow
SERA PROGNOSTICS, INC. (SERA) reported Operating Cash Flow of -$15.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- SERA PROGNOSTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.31M.
- SERA PROGNOSTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.77M.
- SERA PROGNOSTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.12M.
- SERA PROGNOSTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.48M.
- SERA PROGNOSTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$25.62M.
- SERA PROGNOSTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$14.19M.
- SERA PROGNOSTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$27.19M.
- SERA PROGNOSTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$34.61M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$15.09M 10-Q · filed 2026-08-12 | -$21.20M derived: sum of 3 quarters · filed 2026-08-12 | -$27.68M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$8.77M 10-Q · filed 2026-05-06 | -$14.89M derived: sum of 2 quarters · filed 2026-05-06 | -$21.37M derived: sum of 3 quarters · filed 2026-05-06 | -$26.84M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$6.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$12.60M derived: sum of 2 quarters · filed 2026-03-18 | -$18.07M derived: sum of 3 quarters · filed 2026-08-12 | -$25.62M 10-K · filed 2026-03-18 |
| 2025-09-30 | -$6.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$11.95M derived: sum of 2 quarters · filed 2026-08-12 | -$19.50M 10-Q · filed 2025-11-13 | -$25.76M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$5.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$13.03M 10-Q · filed 2026-08-12 | -$19.29M derived: sum of 3 quarters · filed 2026-08-12 | -$26.28M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$7.55M 10-Q · filed 2026-05-06 | -$13.81M derived: sum of 2 quarters · filed 2026-05-06 | -$20.81M derived: sum of 3 quarters · filed 2026-05-06 | -$26.74M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$13.26M derived: sum of 2 quarters · filed 2026-03-18 | -$19.18M derived: sum of 3 quarters · filed 2026-03-18 | -$14.19M 10-K · filed 2026-03-18 |
| 2024-09-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$12.92M derived: sum of 2 quarters · filed 2025-11-13 | -$7.93M 10-Q · filed 2025-11-13 | -$14.69M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$5.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$934.00K 10-Q · filed 2025-08-06 | -$7.70M derived: sum of 3 quarters · filed 2025-08-06 | -$15.29M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $4.99M 10-Q · filed 2025-05-07 | -$1.77M derived: sum of 2 quarters · filed 2025-05-07 | -$9.37M derived: sum of 3 quarters · filed 2025-05-07 | -$17.31M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$6.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$14.36M derived: sum of 2 quarters · filed 2025-03-19 | -$22.31M derived: sum of 3 quarters · filed 2025-03-19 | -$27.19M 10-K · filed 2025-03-19 |
| 2023-09-30 | -$7.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$15.54M derived: sum of 2 quarters · filed 2024-11-06 | -$20.42M 10-Q · filed 2024-11-06 | -$27.66M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$7.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$12.83M 10-Q · filed 2024-08-07 | -$20.07M derived: sum of 3 quarters · filed 2024-08-07 | -$28.84M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$4.88M 10-Q · filed 2024-05-08 | -$12.12M derived: sum of 2 quarters · filed 2024-05-08 | -$20.90M derived: sum of 3 quarters · filed 2024-05-08 | -$29.93M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$7.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$16.02M derived: sum of 2 quarters · filed 2024-03-20 | -$25.05M derived: sum of 3 quarters · filed 2024-03-20 | -$34.61M 10-K · filed 2024-03-20 |
| 2022-09-30 | -$8.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$17.82M derived: sum of 2 quarters · filed 2023-11-08 | -$27.37M 10-Q · filed 2023-11-08 | -$36.52M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$9.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$18.59M 10-Q · filed 2023-08-09 | -$27.75M derived: sum of 3 quarters · filed 2023-08-09 | -$37.04M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$9.56M 10-Q · filed 2023-05-10 | -$18.71M derived: sum of 2 quarters · filed 2023-05-10 | -$28.00M derived: sum of 3 quarters · filed 2023-05-10 | -$34.24M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$9.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$18.45M derived: sum of 2 quarters · filed 2023-03-22 | -$24.69M derived: sum of 3 quarters · filed 2023-03-22 | -$31.64M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$15.53M derived: sum of 2 quarters · filed 2022-11-09 | -$22.48M 10-Q · filed 2022-11-09 | -$26.67M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$6.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$13.19M 10-Q · filed 2022-08-10 | -$17.37M derived: sum of 3 quarters · filed 2022-08-10 | -$21.30M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$6.95M 10-Q · filed 2022-05-10 | -$11.13M derived: sum of 2 quarters · filed 2022-05-10 | -$15.06M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$8.11M derived: sum of 2 quarters · filed 2022-03-29 | -$16.87M 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$3.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$12.68M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$8.76M 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |